BIOVITRUM
Biovitrum is an international pharmaceutical company that markets specialist pharmaceuticals in several regions globally. Using its expertise and experience Biovitrum takes scientific innovation to patients with significant unmet medical need. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within our prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company has revenues of approximately SEK 1.2 billion and around 400 employees. The company head office is located in Sweden. In 2009, Biovitrum merged with [Swedish Orphan](/organization/swedish-orphan), and the combined company has subsequently been rebranded as Swedish Orphan Biovitrum.
BIOVITRUM
Industry:
Biotechnology Health Care
Founded:
2001-01-01
Address:
Stockholm, Stockholms Lan, Sweden
Country:
Sweden
Website Url:
http://www.biovitrum.com
Total Employee:
501+
Status:
Active
Contact:
46 86 97 20 00
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
SPF Domain Not Resolving Microsoft DMARC Microsoft Azure Barracuda Networks Akamai Hosted Microsoft Azure Europe North Region
Similar Organizations
Merck
Merck is a pharmaceutical and chemical enterprise that develops prescription drugs and over-the-counter products.
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2005-08-22 | Arexis AB | Arexis AB acquired by Biovitrum | N/A |
| 2005-03-21 | Cambridge Biotechnology | Cambridge Biotechnology acquired by Biovitrum | N/A |
Investors List
Alta Partners
Alta Partners investment in Venture Round - Biovitrum
HBM Healthcare Investments AG
HBM Healthcare Investments AG investment in Venture Round - Biovitrum
